fbpx

News

Lundbeckfonden Ventures News

Lund, Sweden, (PRNEWSWIRE) June 18, 2014 – BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to ortphopedic surgery, announced initiation of a CERAMENTT’G Bone Healing study by the CHUV (Centre Hospitalier Universitaire Vaudous), in Lausanne, Switzerland. The CERAMENTT’G Bone Healing study is a prospective, controlled, cohort...
Paris, France – 17 June 2014 ENTEROME Bioscience SA, a pioneer in the development of innovative disease management solutions based on a deep understanding of the gut microbiome, is pleased to announce that Pierre Belichard, its Chief Executive Officer, will participate in a panel entitled Microbiome Modulators: Opportunities and Challenges to Creating a New Drug...
— Study to Define Impact of Beta-Lactam Antibiotics on Intestinal Bacteria — Rockville, MD, and Paris, France, June 10, 2014 – Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, and Enterome Bioscience SA, a pioneer in the development of...
SAN DIEGO, June 9, 2014 (GLOBE NEWSWIRE) — Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the field of SERCA enzymes, today announced it has appointed Elizabeth E. Reed as Vice President and General Counsel. Ms. Reed has more than 15 years of legal and...
SAN DIEGO, June 2, 2014 (GLOBE NEWSWIRE) — Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the field of SERCA enzymes, today announced it has appointed Paul Cleveland President and Chief Financial Officer. Mr. Cleveland brings decades of industry experience to his new leadership position....
Features clinical indications for CERAMENTT'BONE VOID FILLER
1 41 42 43 44 45 58

Lundbeckfonden Ventures

News

Acacia Pharma Group PLC – Acacia Pharma Group plc – Issue of Equity on Exercise of Options
16. August 2019
Acacia Pharma Group PLC – Acacia Pharma Group plc: Notice of Interim Results
12. August 2019
Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)
31. July 2019